R. C. Green

发表

The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network.

Marc S. Williams, W. Chung, H. Hakonarson, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Improved provider preparedness through an 8-part genetics and genomic education program.

M. Murray, K. Christensen, R. C. Green, 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study

A. McGuire, A. Beggs, I. Holm, 2022, Frontiers in Genetics.

A framework evaluating the utility of multi-gene, multi-disease population-based panel testing that accounts for uncertainty in penetrance estimates

Jane W. Liang, P. Kraft, K. Christensen, 2022, bioRxiv.

A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases

Laurie D. Smith, Scott D. Kahn, G. Del Angel, 2022, American journal of human genetics.

Public willingness to participate in population DNA screening in Australia

A. Bakshi, I. Winship, J. Tiller, 2022, Journal of medical genetics.

Awareness and utilization of genetic testing among Hispanic and Latino adults living in the US: The Hispanic Community Health Study/Study of Latinos

T. Sofer, Jianwen Cai, C. Isasi, 2022, HGG advances.

Reducing False‐Positive Incidental Findings with Ensemble Genotyping and Logistic Regression Based Variant Filtering Methods

In-Hee Lee, Kyu-Baek Hwang, Tina Hambuch, 2014, Human mutation.

Prioritizing Disease‐Linked Variants, Genes, and Pathways with an Interactive Whole‐Genome Analysis Pipeline

In-Hee Lee, Kyu-Baek Hwang, Isaac S Kohane, 2014, Human mutation.

Short Term Costs of Integrating Whole Genome Sequencing into Primary Care and Cardiology Settings: A Pilot Randomized Trial

Robert C. Green, Natasha K. Stout, Heidi L. Rehm, 2018, Genetics in Medicine.

Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization

Matthew S. Lebo, H. Rehm, J. Smoller, 2021, medRxiv.

Patient understanding of, satisfaction with, and perceived utility of whole genome sequencing: Findings from the MedSeq Project

R. Green, A. McGuire, P. Diamond, 2017, Genetics in Medicine.

Improving Access to HLA-Matched Kidney Transplants for African American Patients

S. Khuder, M. Rees, S. Stepkowski, 2022, Frontiers in Immunology.

Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing.

J. Roberts, M. Ruffin, A. H. Maitland‐van der Zee, 2016, Annals of internal medicine.

Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.

N. Lennon, W. Chung, H. Hakonarson, 2022, JAMA oncology.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, H. Rehm, K. Goddard, 2018, Genetics in Medicine.

Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.

J. Lupski, L. Biesecker, R. C. Green, 2013, JAMA.

Management of Incidental Findings in Clinical Genomic Sequencing

R. Green, J. Krier, R. C. Green, 2015, Current protocols in human genetics.

Management of Incidental Findings in Clinical Genomic Sequencing

R. Green, J. Krier, R. C. Green, 2013, Current protocols in human genetics.

Prioritizing the detection of rare pathogenic variants in population screening

R. Manchanda, P. Lacaze, R. C. Green, 2023, Nature Reviews Genetics.

A framework evaluating the utility of multi-gene, multi-disease population-based panel testing that accounts for uncertainty in penetrance estimates

Jane W. Liang, P. Kraft, K. Christensen, 2023, bioRxiv.

Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium

Madeleine P. Ball, M. Ball, G. Church, 2019, Genome Medicine.

Characterizing genetic variants for clinical action

Kensaku Kawamoto, Nazneen Rahman, Elaine Lyon, 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

A framework evaluating the utility of multi-gene, multi-disease population-based panel testing that accounts for uncertainty in penetrance estimates

Jane W. Liang, P. Kraft, K. Christensen, 2024, bioRxiv.

Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction

I. J. Kullo, K. Christensen, H. Jouni, 2016, Clinical genetics.

Do research participants share genomic screening results with family members?

W. Chung, P. Appelbaum, I. Kullo, 2021, Journal of genetic counseling.

Diet and exercise changes following direct-to-consumer personal genomic testing

M. Couper, A. Kiefer, P. Kraft, 2017, BMC Medical Genomics.

Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers

M. Couper, J. Mountain, J. Roberts, 2014, Genome Medicine.

Parents' decision-making regarding whether to receive adult-onset only genetic findings for their children: Findings from the BabySeq Project.

Matthew S. Lebo, H. Rehm, S. Waisbren, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, H. Rehm, K. Goddard, 2019, Genetics in Medicine.

Are physicians prepared for whole genome sequencing? a qualitative analysis

Denise L. Perry, R. Green, A. McGuire, 2016, Clinical genetics.

Factors Affecting Recall of Different Types of Personal Genetic Information about Alzheimer’s Disease Risk: The REVEAL Study

L. Cupples, K. Christensen, S. Sanderson, 2015 .

Medical Evaluation of Unanticipated Monogenic Disease Risks Identified through Newborn Genomic Screening: Findings from the BabySeq Project

H. Rehm, T. Yu, O. Ceyhan-Birsoy, 2022, medRxiv.

Perspectives of Rare Disease Experts on Newborn Genome Sequencing

R. Ganetzky, I. Holm, J. Wiggs, 2023, JAMA network open.

Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal.

S. Wolf, R. C. Green, 2023, Annual review of genomics and human genetics.

Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.

R. Green, J. Roberts, Catharine Wang, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SLCO1B1 gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatin.

Christine Y. Lu, K. Christensen, A. Wu, 2023, Pharmacogenomics.

Workforce Considerations When Building a Precision Medicine Program

K. Christensen, Megan Bell, R. C. Green, 2022, Journal of personalized medicine.

Attitudes about pharmacogenomic testing vary by healthcare specialty.

K. Christensen, R. C. Green, C. L. Blout Zawatsky, 2023, Pharmacogenomics.

The genomics of emerging pathogens.

J. Hirschhorn, A. Goldstein, K. Christensen, 2013, Annual review of genomics and human genetics.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, K. Goddard, L. Hindorff, 2018, Genetics in Medicine.

Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience

Robert Cook-Deegan, Robert C Green, Kurt D Christensen, 2008, Genetics in Medicine.